Visbiome High Potency Probiotic .

In the mid-1990s, Professor Claudio De Simone, M.D. invented a proprietary blend of probiotic strains (the “De Simone Formulation”). In collaboration with VSL Pharmaceuticals, Inc. he produced and marketed his formula as ‘VSL#3,’ a trademarked and owned by VSL Pharmaceuticals, Inc. During 2014, Professor De Simone decided to leave VSL Pharmaceuticals and shortly after collaborated with ExeGi Pharma, LLC to produce Visbiome High Potency Probiotic , a probiotic using the same proprietary blend of probiotic strains that De Simone originally invented. De Simone Formulation, one of the most widely studied probiotics with over 60 published human clinical studies.

Visbiome High Potency Probiotic is a generic equivalent of the VSL#3®?

De Simone Formulation contains the same strains as VSL#3® probiotic blend as produced before January 31, 2016.

De Simone Formulation Ingredients:

1.Lactobacillus paracasei DSM 24733

2.Lactobacillus plantarum DSM 24730

3.Lactobacillus acidophilus DSM 24735

4.Lactobacillus delbruecki subspecies bulgaricus DSM 24734

5.Bifidobacterium longum DSM 24736

6.Bifidobacterium infantis DSM 24737

7.Streptococcus thermophilus DSM 24731

Inactive ingredients: microcrystalline cellulose, stearic acid, magnesium stearate, and vegetable capsule (hydroxypropyl methycellulose), silicon dioxide

This new Visbiome probiotic formula is not really new at all. In fact, Professor Claudio De Simone invented the formula in the mid-1990s. Visibiome probiotic has been on the market under the “VSL#3®*” brand since 2003. Some time in in early 2015 Professor De Simone began working with ExeGi Pharma, LLC to produce Visbiome probiotic. Visbiome probiotic contains the same formulation as found in the VSL#3®* probiotic blend produced before January 31, 2016. Most importantly VSL#3® is a registered trademark of VSL Pharmaceuticals, Inc. Visbiome probiotic is manufactured exclusively for ExeGi Pharma, LLC. Probiotic Visibiome is not affiliated with, endorsed by, or distributed by VSL Pharmaceuticals, Inc.
Visbiome High Potency Probiotic formula.

De Simone Formulation contains the same formula as original VSL#3. Most of all Visbiome probiotic manufactured using the original production methods, that the Professor originally invented. Visiobiome probiotic less costly than VSL#3, however some customers using VSL#3* for relief from digestive conditions know how effective this formulation is and switching to Visbiome..

What is the most important thing to know about De Simone Formulation?

De Simone Formulation is a high potency probiotic medical food. Visbiome containins 8 strains of live bacteria in concentrations of 450 billion bacteria per packet and 112.5 billion per capsule. Probiotic Visbiome intended for the dietary management of the IBD (inflammatory bowel disease), ulcerative colitis, of an ileal pouch and of IBS (irritable bowel syndrome)

Most importantly Visbiome probiotic contains the De Simone Formulation. While other probiotics claim their ability to perform without any clinical proof. De Simone Formulation is one of the most widely studied probiotics with over 60 published human clinical studies. Visbiome is being used in more than 20 trials worldwide.

Due to the same formulation De Simone Formulation acts as the generic equivalent of the VSL#3*

Most importantly Visbiome is a medical food intended for use under the supervision of a physician.

Visbiome Capsules contains 112.5 Billion strains and usually taken 2 to 8 capsules daily. While Visbiome probiotic Packets are taken 1 to 2 daily and contain 450 Billion strains per Sachet. As a result taking four Visbiome probiotic Capsules is equal of taking one Visbiome Packet.
In conclusion Visbiome DS is a double strain and contains 900 Billion strains and by prescription only.

Finally De Simone Formulation is stored under refrigerated conditions (39-46°F, 4-8°C) to ensure maximum potency.

Most impotently, ExeGi Pharma recently received a product license from the Health Canada Natural and Non-prescription Health Products Directorate for the company’s generic probiotic Visbiome.